Cargando…

Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer

Mesothelin (MSLN) overexpression (OE) is a frequent finding in ovarian carcinomas and increases cell survival and tumor aggressiveness. Since cancer stem cells (CSCs) contribute to pathogenesis, chemoresistance and malignant behavior in ovarian cancer (OC), we hypothesized that MSLN expression could...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nunes, Mariana, Pacheco, Francisca, Coelho, Ricardo, Leitão, Dina, Ricardo, Sara, David, Leonor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834752/ https://www.ncbi.nlm.nih.gov/pubmed/35162954 http://dx.doi.org/10.3390/ijms23031016

Ejemplares similares

Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
por: Coelho, Ricardo, et al.
Publicado: (2020)

Targeting mesothelin in ovarian cancer
por: Ghafoor, Azam, et al.
Publicado: (2018)

The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
por: Hilliard, Tyvette S.
Publicado: (2018)

The hen model of human ovarian cancer develops anti-mesothelin autoantibodies in response to mesothelin expressing tumors
por: Yu, Yi, et al.
Publicado: (2011)

Characterization of human mesothelin transcripts in ovarian and pancreatic cancer
por: Muminova, Zhanat E, et al.
Publicado: (2004)

An engineered T-cell engager with selectivity for high mesothelin-expressing cells and activity in the presence of soluble mesothelin
por: Snell, Daniel, et al.
Publicado: (2023)

High Homogeneity of Mesothelin Expression in Primary and Metastatic Ovarian Cancer
por: Weidemann, Sören, et al.
Publicado: (2023)

Host Mesothelin Expression Increases Ovarian Cancer Metastasis in the Peritoneal Microenvironment
por: Hilliard, Tyvette S., et al.
Publicado: (2021)

Prognostic and predictive value of ALDH1, SOX2 and SSEA-4 in bladder cancer
por: Blomqvist, Matias, et al.
Publicado: (2021)

Induced Expression of Cancer Stem Cell Markers ALDH1A3 and Sox-2 in Hierarchical Reconstitution of Apoptosis-resistant Human Breast Cancer Cells
por: Kashii-Magaribuchi, Karin, et al.
Publicado: (2016)

Clinicopathological characteristics and prognostic value of the cancer stem cell marker ALDH1 in ovarian cancer: a meta-analysis
por: Zhao, Wenge, et al.
Publicado: (2018)

Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
por: Matsuzawa, Fumihiko, et al.
Publicado: (2021)

Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma
por: Creaney, Jenette, et al.
Publicado: (2014)

Low serum mesothelin in pancreatic cancer patients results from retention of shed mesothelin in the tumor microenvironment
por: Zhang, Xianyu, et al.
Publicado: (2022)

ALDH1 Expression Correlates with Favorable Prognosis in Ovarian Cancers
por: Chang, Bin, et al.
Publicado: (2009)

Recycling the Purpose of Old Drugs to Treat Ovarian Cancer
por: Nunes, Mariana, et al.
Publicado: (2020)

Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
por: Einama, Takahiro, et al.
Publicado: (2017)

Rat N-ERC/Mesothelin as a Marker for In Vivo Screening of Drugs against Pancreas Cancer
por: Fukamachi, Katsumi, et al.
Publicado: (2014)

High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma
por: Cheng, W-F, et al.
Publicado: (2009)

Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
por: Shen, Jiayu, et al.
Publicado: (2020)

Altered Presence of Cancer Stem Cell ALDH1/2 in Oral Leukoplakias and Squamous Cell Carcinomas
por: Zisis, Vasileios, et al.
Publicado: (2023)

The Expanding Role of Cancer Stem Cell Marker ALDH1A3 in Cancer and Beyond
por: McLean, Meghan E., et al.
Publicado: (2023)

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

SOX2 is required to maintain cancer stem cells in ovarian cancer
por: Wen, Yiping, et al.
Publicado: (2017)

Preoperative Serum Levels of Mesothelin in Patients with Colon Cancer
por: Bostancı, Özgür, et al.
Publicado: (2014)

Multiple proteases are involved in mesothelin shedding by cancer cells
por: Liu, Xiufen, et al.
Publicado: (2020)

Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer
por: Heerma van Voss, Marise R., et al.
Publicado: (2011)

Methylation-Associated Partial Down-Regulation of Mesothelin Causes Resistance to Anti-Mesothelin Immunotoxins in a Pancreatic Cancer Cell Line
por: Hollevoet, Kevin, et al.
Publicado: (2015)

ALDH1 Cancer Stem Cell Marker as a Prognostic Factor in Triple-Negative Breast Cancer
por: Panigoro, Sonar Soni, et al.
Publicado: (2020)

The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression
por: Tsochantaridis, Ilias, et al.
Publicado: (2023)

Inhibition of Mesothelin as a Novel Strategy for Targeting Cancer Cells
por: Wang, Kun, et al.
Publicado: (2012)

Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
por: White, Michael, et al.
Publicado: (2018)

Structures of Cancer Antigen Mesothelin and Its Complexes with Therapeutic Antibodies
por: Zhan, Jingyu, et al.
Publicado: (2023)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants*
por: Fausther, Michel, et al.
Publicado: (2017)

Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019)

Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin
por: Liu, Xiufen, et al.
Publicado: (2022)

Anti-Proliferation Effect of Theasaponin E(1) on the ALDH-Positive Ovarian Cancer Stem-Like Cells
por: Jia, Ling-Yan, et al.
Publicado: (2018)

Prognostic Value of Cancer Stem Cell Markers CD44 and ALDH1/2 in Gastric Cancer Cases
por: Senel, Fatma, et al.
Publicado: (2017)

Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium
por: Ugai, Tomotaka, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5bkalsinkksp3ea5jod1dgfmpc